Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Mountain View, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
26
Frequently Asked Questions
What is Market Cap of Aditxt Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aditxt Inc market cap is $1.07M.
What is the 52-week high for Aditxt Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aditxt Inc 52 week high is $207.45 as of October 25, 2025.
What is the 52-week low for Aditxt Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aditxt Inc 52 week low is $0.2075 as of October 25, 2025.
What is the PE ratio of Aditxt Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aditxt Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Aditxt Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aditxt Inc P/B ratio is 0.0527.
What is the 50-day moving average of Aditxt Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aditxt Inc 50-day moving average is $0.8221.
